[1] |
KongF, GowanS, MartinD,et al. Serotype identification of group B streptococci by PCR and sequencing[J]. J Clin Microbiol,2002,40(1):216-226.
|
[2] |
CorrêaAB, OliveiraIC, Pinto TdeC,et al. Pulsed-field gel electrophoresis, virulence determinants and antimicrobial susceptibility profiles of type Ⅰa group B streptococci isolated from humans in Brazil[J]. Mem Inst Oswaldo Cruz,2009,104(4):599-603.
|
[3] |
ImperiM, PataracchiaM, AlfaroneG,et al. A multiplex PCR assay for the direct identification of the capsular type(Ⅰa to Ⅸ) of Streptococcus agalactiae[J].J Microbiol Methods,2010,80(2):212-214.
|
[4] |
BolukaotoJY, MonyamaCM, ChukwuMO,et al.Antibiotic resistance of Streptococcus agalactiae isolated from pregnant women in Garankuwa, South Africa[J].BMC Res Notes,2015,8:364.
|
[5] |
DesjardinsM, DelgatyKL, RamotarK, et al. Prevalence and mechanisms of erythromycin resistance in group A and group B streptococcus: implications for reporting susceptibility results[J].J Clin Microbiol,2004,42(12):5620-5623.
|
[6] |
JonesN, BohnsackJF, TakahashiS,et al. Multilocus sequence typing system for group B streptococcus[J].J Clin Microbiol,2003,41(6):2530-2536.
|
[7] |
VeraniJR, McGeeL, SchragSJ. Prevention of perinatal group B streptococcal disease-revised guidelines from CDC, 2010[J].MMWR Recomm Rep,2010,59(RR-10):1-36.
|
[8] |
GygaxSE, SchuylerJA, KimmelLE, et al. Erythromycin and clindamycin resistance in group B streptococcal clinical GBS strains[J].Antimicrob Agents Chemother,2006,50(5):1875-1877.
|
[9] |
Crespo-Ortiz MdelP, Castañeda-RamirezCR, Recalde-BolañosM,et al.Emerging trends in invasive and noninvasive GBS strains of Streptococcus agalactiae in a Latin American hospital:a 17-year study[J].BMC Infect Dis,2014,14:428.
|
[10] |
StaffordIA,StewartRD,SheffieldJS,et al. Efficacy of maternal and neonatal chemoprophylaxis for early-onset group B streptococcal disease[J].Obstet Gynecol,2012,120(1):123-129.
|
[11] |
LuB,LiD,CuiY,et al. Epidemiology of Group B streptococcus isolated from pregnant women in Beijing, China[J].Clin Microbiol Infect,2014,20(6):O370-O373.
|
[12] |
GoudarziG, GhafarzadehM, ShakibP,et al.Culture and real-time pcr based maternal screening and antibiotic susceptibility for group B streptococcus: an iranian experience[J].Glob J Health Sci,2015,7(6):233-239.
|
[13] |
BeigverdiR, JabalameliF, MirsalehianA,et al.Virulence factors, antimicrobial susceptibility and molecular characterization of Streptococcus agalactiae isolated from pregnant women[J].Acta Microbiol Immunol Hung,2014,61(4):425-434.
|
[14] |
WolduZL, TeklehaimanotTG, WajiST,et al. The prevalence of Group B Streptococus recto-vaginal colonization and antimicrobial susceptibility pattern in pregnant mothers at two hospitals of Addis Ababa, Ethiopia[J].Reprod Health,2014,11:80.
|
[15] |
AbarzúaF, ArgomedoC, MeissnerA,et al. Prevalence of anal-vaginal colonization of Streptococcus agalactiae in third trimester of pregnancy and susceptibility to macrolides and lincosamides, in pregnant women controlled at Clínica Alemana Temuco, Southern Chile[J]. Rev Chilena Infectol,2014,31(3):305-308.
|
[16] |
ShabayekS, AbdallaS. Macrolide- and tetracycline-resistance determinants of colonizing group B streptococcus in women in Egypt[J].J Med Microbiol,2014,63(Pt 10):1324-1327.
|
[17] |
FröhlicherS, Reichen-FahrniG, MüllerM,et al. Serotype distribution and antimicrobial susceptibility of group B streptococci in pregnant women: results from a Swiss tertiary centre[J].Swiss Med Wkly,2014,144:w13935.
|
[18] |
LiakopoulosA, MavroidiA, VourliS,et al. Molecular characterization of Streptococcus agalactiae from vaginal colonization and neonatal infections: a 4-year multicenter study in Greece[J].Diagn Microbiol Infect Dis,2014,78(4):487-490.
|
[19] |
TurnerC,TurnerP,PoL,et al.Group B streptococcal carriage,serotype distribution and antibiotic susceptibilities in pregnant women at the time of delivery in a refugee population on the Thai-Myanmar border[J].BMC Infect Dis,2012,12:34.
|
[20] |
MorozumiM, WajimaT, KuwataY,et al. Associations between capsular serotype, multilocus sequence type, and macrolide resistance in Streptococcus agalactiae isolates from Japanese infants with invasive infections[J].Epidemiol Infect,2014,142(4):812-819.
|
[21] |
WangP, MaZ, TongJ,et al.Serotype distribution, antimicrobial resistance, and molecular characterization of invasive group B Streptococcus isolates recovered from Chinese neonates[J].Int J Infect Dis,2015,37:115-118.
|
[22] |
ChangB, WadaA, HosoyaM,et al. Characteristics of group B Streptococcus isolated from infants with invasive infections: a population-based study in Japan[J]. Jpn J Infect Dis,2014,67(5):356-360.
|
[23] |
WangYH,ChenCL,HouJN,et al. Serotype distribution and resistance genes associated with macrolide and fluoroquinolone resistance in Streptococcus agalactiae isolates from a hospital in southern Taiwan[J].Biomed J,2015,38(3):215-220.
|
[24] |
DutraVG, AlvesVM, OlendzkiAN,et al. Streptococcus agalactiae in Brazil: serotype distribution, virulence determinants and antimicrobial susceptibility[J].BMC Infect Dis,2014,14:323.
|
[25] |
SoaresGC, AlvianoDS, da Silva SantosG,et al. Prevalence of Group B Streptococcus serotypes Ⅲ and Ⅴ in pregnant women of Rio de Janeiro, Brazil[J].Braz J Microbiol,2014,44(3):869-872.
|
[26] |
OtaguiriES, MorguetteAE, TavaresER,et al.Commensal Streptococcus agalactiae isolated from patients seen at University Hospital of Londrina, Paraná,Brazil: capsular types, genotyping, antimicrobial susceptibility and virulence determinants[J].BMC Microbiol,2013,13:297.
|
[27] |
MartinsER, AndreuA, CorreiaP,et al.Group B streptococci causing neonatal infections in barcelona are a stable clonal population:18-year surveillance[J].J Clin Microbiol,2011,49(8):2911-2918.
|